Together, the data suggest that the combination of CB-839 and 5-FU activates NRF2 transcriptional activity in CRC cells and induces IL-8 expression, thereby attracting neutrophils into tumors and producing NETs to inhibit tumor xenograft tumor growth. This evidence concerns the gene CXCL8 and colorectal carcinoma.